Previous close | 0.00 |
Open | 20.25 |
Bid | 19.26 x 40700 |
Ask | 19.99 x 34100 |
Day's range | 20.25 - 20.25 |
52-week range | 16.69 - 23.00 |
Volume | |
Avg. volume | 2,232 |
Market cap | 81.155B |
Beta (5Y monthly) | 0.30 |
PE ratio (TTM) | 14.21 |
EPS (TTM) | 1.40 |
Earnings date | 31 Jul 2024 |
Forward dividend & yield | 0.77 (3.88%) |
Ex-dividend date | 16 May 2024 |
1y target est | N/A |
Glaxo (GSK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Harvey Jones is building his Stocks and Shares ISA around seven FTSE 100 dividend stocks that should slowly reveal their charms over time. The post These boring but beautiful picks will always have a place in my Stocks and Shares ISA appeared first on The Motley Fool UK.
GSK’s share price has fallen on negative developments for two of its drugs, but it still has a strong core business with excellent growth prospects. The post As GSK’s share price drops 15%, should I buy, sell, or hold? appeared first on The Motley Fool UK.